Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 70 Projects
Project # Contact PI Funding Organization Fiscal Year
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease
ADDF-54 Sninsky, John Alzheimer's Drug Discovery Foundation 2022
Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development
ADDF-55 Wilson, David Alzheimer's Drug Discovery Foundation 2022
Validation of the Retinal Deep Phenotyping (TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer's disease
ADDF-31 Sylvestre, Jean-Philippe Alzheimer's Drug Discovery Foundation 2021
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
ADDF-32 Menniti, Frank Alzheimer's Drug Discovery Foundation 2021
Easy and early plasma pTau181 detection with LUMIPULSE G platform as indicator of Alzheimer's disease
ADDF-38 Vandijck, Manu Alzheimer's Drug Discovery Foundation 2021
Validation and commercialization of a novel blood-based, ultra-multiplex Laboratory Developed Test (LDT) for the prediction of cerebral amyloid status before clinical onset of dementia
ADDF-41 Anderson, Leyla Alzheimer's Drug Discovery Foundation 2021
Development of a Biosample Database to Investigate Beta-Amyloid, Phospho-Tau, and Neurofilament Light Chain Blood-Based and Digital Biomarkers in Older Volunteers Screened for Preclinical AD, Prodromal AD, or Mild AD
ADDF-47 Beauregard, Doug Alzheimer's Drug Discovery Foundation 2021
Towards an integral and sensitive neurophysiological risk biomarkers for asymptomatic detection of Alzheimer's disease
ADDF-50 Polania, Rafael Alzheimer's Drug Discovery Foundation 2021
PROSPECT-AD: Population-based scReening Over SPEech for Clinical Trials in AD
ADDF-53 Linz, Nicklas Alzheimer's Drug Discovery Foundation 2021
Digitally-enhanced personalized medicine: Accurate selection of subjective cognitive decline and measuring progression of mild cognitive impairment
ADDF-12 Tarnanas, Ioannis Alzheimer's Drug Discovery Foundation 2020